Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,533
archived clinical trials in
Chronic Obstructive Pulmonary Disease

A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Novartis
2028
mi
from 43215
Portland, OR
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Updated: 1/1/1970
Novartis
2028
mi
from 43215
Portland, OR
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Novartis Investigative Site
524
mi
from 43215
Mt. Pleasant, SC
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Updated: 1/1/1970
Novartis Investigative Site
524
mi
from 43215
Mt. Pleasant, SC
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Novartis Investigative Site
280
mi
from 43215
Knoxville, TN
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Status: Archived
Updated: 1/1/1970
Novartis Investigative Site
280
mi
from 43215
Knoxville, TN
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
University of Miami Hospital
993
mi
from 43215
Miami, FL
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
993
mi
from 43215
Miami, FL
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Temple University
416
mi
from 43215
Philadelphia, PA
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Updated: 1/1/1970
Temple University
416
mi
from 43215
Philadelphia, PA
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
524
mi
from 43215
Charleston, SC
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
1138
mi
from 43215
San Antonio, TX
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
A Randomized Double-blind Crossover Study to Assess the Safety and Pharmacokinetics of Two Different Doses of Weekly Intravenous Administration of Alpha1-Proteinase Inhibitor (Human) Prolastin-C in Subjects With Alpha1-Antitrypsin Deficiency
Status: Archived
Updated: 1/1/1970
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
1138
mi
from 43215
San Antonio, TX
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Asthma and Allergy Center
347
mi
from 43215
Baltimore, MD
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Asthma and Allergy Center
347
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Enhancing Utilization of Non-Invasive Positive Pressure Ventilation in Critical Care
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Evaluation of Airway Gene Expression in COPD and Controlled Populations
Evaluation of Airway Gene Expression in COPD and Controlled Populations
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Evaluation of Airway Gene Expression in COPD and Controlled Populations
Evaluation of Airway Gene Expression in COPD and Controlled Populations
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
682
mi
from 43215
Omaha, NE
Click here to add this to my saved trials
Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure
Safety and Efficacy of Venovenous Carbon Dioxide Removal in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Respiratory Failure (ARF)
Status: Enrolling
Updated:  12/31/1969
University of Texas Medical Branch
992
mi
from 43215
Galveston, TX
Venovenous CO2 Removal (VVCO2R) in Patients With COPD and Acute Respiratory Failure
Safety and Efficacy of Venovenous Carbon Dioxide Removal in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Acute Respiratory Failure (ARF)
Status: Enrolling
Updated: 12/31/1969
University of Texas Medical Branch
992
mi
from 43215
Galveston, TX
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Los Angeles Biomedical Research Institute
1980
mi
from 43215
Torrance, CA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Los Angeles Biomedical Research Institute
1980
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
1160
mi
from 43215
Denver, CO
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
1160
mi
from 43215
Denver, CO
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Morehouse School of Medicine
436
mi
from 43215
Atlanta, GA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Morehouse School of Medicine
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of Iowa
461
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Fallon Clinic
604
mi
from 43215
Worcester, MA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Fallon Clinic
604
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Ann Arbor VA Medical Center
165
mi
from 43215
Ann Arbor, MI
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Ann Arbor VA Medical Center
165
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Medical Center
621
mi
from 43215
Minneapolis, MN
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Medical Center
621
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
HealthPartners Research Foundation
635
mi
from 43215
Minneapolis, MN
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
HealthPartners Research Foundation
635
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Duke University
352
mi
from 43215
Durham, NC
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Temple University
416
mi
from 43215
Philadelphia, PA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Temple University
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
Houston VA Medical Center
995
mi
from 43215
Houston, TX
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
Houston VA Medical Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Sciences Center at San Antonio
1138
mi
from 43215
San Antonio, TX
Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD)
Genetic Epidemiology of Chronic Obstructive Pulmonary Disease
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Sciences Center at San Antonio
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms for COPD: Genetic Determinants: Elastin Quality and Quantity (Project 2)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Evaluating Genetic Factors That May Contribute to Elastin Function and the Development of Chronic Obstructive Pulmonary Disease
Specialized Center of Clinically Oriented Research: Alveolar and Airway Mechanisms for COPD: Genetic Determinants: Elastin Quality and Quantity (Project 2)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Biomarkers and Genetic Factors Related to Emphysema
SCCOR: Alveolar and Airway Mechanisms for COPD Project 3: Membrane-Type 1 Matrix Metalloproteinase and Extracellular Matrix Metalloproteinase Inducer in Cigarette Smoke-Induced Lung Inflammation and Emphysema Pathogenesis
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Biomarkers and Genetic Factors Related to Emphysema
SCCOR: Alveolar and Airway Mechanisms for COPD Project 3: Membrane-Type 1 Matrix Metalloproteinase and Extracellular Matrix Metalloproteinase Inducer in Cigarette Smoke-Induced Lung Inflammation and Emphysema Pathogenesis
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
Comparison of Dobutamine and Regadenoson Stress CMR
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)
Comparison of Dobutamine and Regadenoson Stress CMR
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Baptist Medical Center
306
mi
from 43215
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
628
mi
from 43215
Andalusia, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
628
mi
from 43215
Andalusia, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
417
mi
from 43215
Athens, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
417
mi
from 43215
Athens, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
493
mi
from 43215
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
409
mi
from 43215
Huntsville, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
409
mi
from 43215
Huntsville, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
699
mi
from 43215
Mobile, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
553
mi
from 43215
Montgomery, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
553
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
441
mi
from 43215
Muscle Shoals, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
441
mi
from 43215
Muscle Shoals, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
605
mi
from 43215
Ozark, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
605
mi
from 43215
Ozark, AL
Click here to add this to my saved trials
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
476
mi
from 43215
Pell City, AL
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
A Clinical Outcomes Study to Compare the Effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg With Placebo on Survival in Subjects With Moderate Chronic Obstructive Pulmonary Disease (COPD) and a History of or at Increased Risk for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
476
mi
from 43215
Pell City, AL
Click here to add this to my saved trials